NCT00976261 - A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 17, 2009

Primary Completion Date

September 5, 2010

Study Completion Date

September 5, 2010

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

GSK1614235

Glucose lowering in Type 2 Diabetes Mellitus

DRUG

Sitagliptin

Glucose lowering in Type 2 Diabetes Mellitus

OTHER

Placebo

Comparator

Trial Locations (9)

GSK Investigational Site, Berlin

GSK Investigational Site, Hamburg

GSK Investigational Site, Miami

GSK Investigational Site, Gières

GSK Investigational Site, Neuss

GSK Investigational Site, Cincinnati

GSK Investigational Site, Baton Rouge

GSK Investigational Site, Rueil-Malmaison

GSK Investigational Site, Cambridge